This study is currently not recruiting participants.

Randomised Evaluation of dabigatran etexilate Compared to warfarIn in pulmonaRy vein ablation: assessment of an uninterrupted periproCedUral antIcoagulation sTrategy (The RE-CIRCUIT Trial)

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

The purpose of this study is to assess the safety of an uninterrupted dabigatran etexilate periprocedural anticoagulant regimen compared to an uninterrupted periprocedural warfarin regiment in non-valvular atrial fibrillation patients undergoing AF ablation in a PROBE active controlled study.

Description

The purpose of this study is to assess the safety of an uninterrupted dabigatran etexilate periprocedural anticoagulant regimen compared to an uninterrupted periprocedural warfarin regiment in non-valvular atrial fibrillation patients undergoing AF ablation in a PROBE active controlled study.

Details
Condition atrial fibrillation
Age 100years or below
Clinical Study IdentifierTX5992
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.